| 产品名称: | MDA-MB-453 |
|---|---|
| 商品货号: | TS258879 |
| <strong>Cell line </strong>: | MDA-MB-453 |
| DSMZ no. : | TS258879 |
| Species : | originally confirmed as human with IEF of MDH, NP and recently by STR fingerprinting |
| Cell type : | breast carcinoma |
| Origin : | established from an effusion of a 48-year-old woman with breast carcinoma in 1976 |
| Reference(s) : | 14415, 14960 |
| Biosafety level : | 1 |
| Permissions and restrictions : | A |
| <strong> </strong>: | DSMZ Scientific Data: |
| Morphology: | epithelial-like, round, loosely attached monolayers; image; image |
| Medium : | 90% Leibovitzs L-15 medium + 10% h.i. FBS |
| Subculture : | seed out at 2-4 x 106 cells/80 cm2; split confluent culture 1:2 to 1:6 using trypsin/EDTA; cells can partially be detached by tapping the flask; cells may need several days to re-adhere again |
| Incubation : | at 37 °C, no exposure to CO2 (keep lid of flask closed) |
| Doubling time : | ca. 50-60 hours |
| Harvest : | about 25-35 x 106 cells/80 cm2 |
| Storage : | frozen with 85% medium, 10% FBS, 5% DMSO |
| Mycoplasma : | contamination was eliminated with Ciprobay (ciprofloxacin), then negative in DAPI, microbiological culture, RNA hybridization, PCR assays |
| Immunology : | To inquire about expression of EpCAM and intermediate filaments, contact hilmar.quentmeier@dsmz.de. |
| Fingerprint : | multiplex PCR of minisatellite markers revealed a unique DNA profile |
| Cytogenetics : | human hypotetraploid karyotype with 6% polyploidy and near diploid sideline (2%) - 89(85-91)<4n>XXX, -X - highly rearranged leading to extensive marker formation, including der(5)t(5;?14)(p11;q11)x2 - dm present in 12% cells |
| Viruses : | ELISA: reverse transcriptase negative; PCR: EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-I/II -, MLV -, SMRV - |
| 产品名称: | MDA-MB-453 |
|---|---|
| 商品货号: | TS258879 |
| <strong>Cell line </strong>: | MDA-MB-453 |
| DSMZ no. : | TS258879 |
| Species : | originally confirmed as human with IEF of MDH, NP and recently by STR fingerprinting |
| Cell type : | breast carcinoma |
| Origin : | established from an effusion of a 48-year-old woman with breast carcinoma in 1976 |
| Reference(s) : | 14415, 14960 |
| Biosafety level : | 1 |
| Permissions and restrictions : | A |
| <strong> </strong>: | DSMZ Scientific Data: |
| Morphology: | epithelial-like, round, loosely attached monolayers; image; image |
| Medium : | 90% Leibovitzs L-15 medium + 10% h.i. FBS |
| Subculture : | seed out at 2-4 x 106 cells/80 cm2; split confluent culture 1:2 to 1:6 using trypsin/EDTA; cells can partially be detached by tapping the flask; cells may need several days to re-adhere again |
| Incubation : | at 37 °C, no exposure to CO2 (keep lid of flask closed) |
| Doubling time : | ca. 50-60 hours |
| Harvest : | about 25-35 x 106 cells/80 cm2 |
| Storage : | frozen with 85% medium, 10% FBS, 5% DMSO |
| Mycoplasma : | contamination was eliminated with Ciprobay (ciprofloxacin), then negative in DAPI, microbiological culture, RNA hybridization, PCR assays |
| Immunology : | To inquire about expression of EpCAM and intermediate filaments, contact hilmar.quentmeier@dsmz.de. |
| Fingerprint : | multiplex PCR of minisatellite markers revealed a unique DNA profile |
| Cytogenetics : | human hypotetraploid karyotype with 6% polyploidy and near diploid sideline (2%) - 89(85-91)<4n>XXX, -X - highly rearranged leading to extensive marker formation, including der(5)t(5;?14)(p11;q11)x2 - dm present in 12% cells |
| Viruses : | ELISA: reverse transcriptase negative; PCR: EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-I/II -, MLV -, SMRV - |